|
MEX3C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.325000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.407000E-01 |
| Normal-vs-Stage2 |
3.102600E-01 |
| Normal-vs-Stage3 |
1.112170E-02 |
| Normal-vs-Stage4 |
2.396800E-01 |
| Stage1-vs-Stage2 |
1.646560E-01 |
| Stage1-vs-Stage3 |
2.248100E-04 |
| Stage1-vs-Stage4 |
8.804400E-02 |
| Stage2-vs-Stage3 |
2.801000E-01 |
| Stage2-vs-Stage4 |
9.521600E-01 |
| Stage3-vs-Stage4 |
2.804000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.706400E-01 |
| Normal-vs-AfricanAmerican |
9.135600E-01 |
| Normal-vs-Asian |
9.516400E-01 |
| Caucasian-vs-AfricanAmerican |
6.172800E-01 |
| Caucasian-vs-Asian |
7.961400E-01 |
| AfricanAmerican-vs-Asian |
9.974600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.358200E-01 |
| Normal-vs-Female |
9.828400E-01 |
| Male-vs-Female |
1.055960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.799200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.698600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.581000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.143600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.026790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.915900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.280300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.049600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.386200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.766180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.489360E-01 |
| Normal-vs-Grade 2 |
4.190600E-01 |
| Normal-vs-Grade 3 |
6.342300E-03 |
| Normal-vs-Grade 4 |
1.468580E-01 |
| Grade 1-vs-Grade 2 |
3.820800E-01 |
| Grade 1-vs-Grade 3 |
2.379500E-03 |
| Grade 1-vs-Grade 4 |
3.179500E-02 |
| Grade 2-vs-Grade 3 |
1.50329999999421E-05 |
| Grade 2-vs-Grade 4 |
2.419800E-02 |
| Grade 3-vs-Grade 4 |
4.242800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.400000E-01 |
| Normal-vs-ccB subtype |
5.706600E-01 |
| ccA subtype-vs-ccB subtype |
3.430800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.135200E-01 |
| Normal-vs-N1 |
9.322600E-01 |
| N0-vs-N1 |
6.722400E-01 |
|
|
